Why Linde’s recent performance is drawing attention
Linde (LIN), a global industrial gas company, is back on many investors’ radars after a solid past 3 months, with the share price posting a total return above 14%.
That move follows a longer run of positive multi year total returns and sits alongside annual revenue of US$33.99b and net income of US$6.90b. This combination is prompting closer scrutiny of what is currently priced in.
See our latest analysis for Linde.
Over the past year, Linde’s share price has moved more modestly than its recent 90 day momentum, with a 1 year total shareholder return of 7.76% compared with a 46.21% total return over three years and 85.97% over five years. This suggests investors are reassessing growth prospects and risks after a strong multi year run at a current share price of US$488.15.
If you are looking for other ideas beyond large industrial names, it can be useful to see where capital is flowing into AI infrastructure and related suppliers through 34 AI infrastructure stocks.
With a recent 14% total return in 90 days, annual net income of US$6.90b and a last close of US$488.15, the real question is whether Linde is still undervalued or if the market is already pricing in future growth.
Most Popular Narrative: 3.1% Undervalued
With Linde’s last close at $488.15 and the narrative fair value at $503.52, the current setup focuses attention on what is built into long term assumptions.
Linde's project backlog has doubled over the last 4 years, anchored by long-term, fixed-fee contracts supporting U.S. clean energy and electronics infrastructure, and management expects this robust pipeline to remain at record levels, positioning the company for steady multi-year revenue and earnings growth. Strategic investments and customer commitments in rapidly expanding growth markets such as commercial space launches, electronics, and clean hydrogen (with almost $5 billion in new clean energy contracts) provide a runway for high-margin revenue streams and new project conversion that will structurally lift blended margins and earnings.
Want to see what justifies paying up for those future earnings? The narrative leans on multi year revenue expansion, rising margins and a richer profit multiple. The exact mix of growth, profitability and required return is where the story gets interesting.
Result: Fair Value of $503.52 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this hinges on industrial demand holding up, and a slower energy transition or weaker volumes in Europe and Asia could quickly challenge that optimism.
Find out about the key risks to this Linde narrative.
Another way to look at valuation
The fair value narrative suggests Linde is 3.1% undervalued at US$503.52, but the P/E tells a different story. At 32.8x, the shares trade above the US Chemicals industry on 26.2x and above a fair ratio of 27.3x. This points to richer expectations and less room for error.
For many investors, that gap raises a simple question: is this a quality premium that feels reasonable, or a valuation that leaves little cushion if growth or margins fall short of consensus assumptions?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Curious whether the optimism in this article really outweighs the concerns investors still have? Take a closer look at the evidence on both sides with 2 key rewards and 2 important warning signs
Looking for more investment ideas?
Do not stop with a single company when you can quickly scan the market for other opportunities that might fit your goals just as well or even better.
- Target strong quality at a reasonable entry point by reviewing companies flagged as 54 high quality undervalued stocks.
- Prioritise resilience by checking out 70 resilient stocks with low risk scores that aim to keep volatility in check while still offering potential upside.
- Spot early stage potential by scanning the market for 33 elite penny stocks with strong financials that already show solid fundamentals instead of just hype.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com